Micro-Ultrasound and MRI for Prostate Cancer Active Surveillance
This study is comparing two imaging methods, high-resolution micro-ultrasound (microUS) and MRI, to see which is better at detecting significant prostate cancer in men who are on active surveillance. Active surveillance means closely monitoring prostate cancer that is not immediately treated. You may be eligible if you are an adult man with Gleason Grade Group 1 prostate cancer (a low-risk type) who needs a follow-up biopsy. The main goal is to see if microUS or MRI is more accurate at finding cancer that has progressed to a higher-risk type (Gleason Grade Group 2 or higher) during a confirmatory biopsy. The study plans to enroll 210 participants, but its current status is unclear.
- Study design
- This interventional study plans to enroll 210 adult men. It compares micro-ultrasound and MRI during a single biopsy session.
- What's involved
- You would undergo a biopsy session where samples are taken using micro-ultrasound, then MRI-guided sampling, followed by 12 systematic biopsy cores. Blood samples will also be collected.
- Compensation
- Not stated in the trial record.
- Follow-up
- Cancer upgrading is measured immediately after biopsy.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Micro-UltraSound In Cancer - Active Surveillance
At a glance
Conditions
Where it's being run
6 sites across 5 statesStudy leadership
- Adam Kinnaird, MD, PhD · PRINCIPAL_INVESTIGATOR · University of Alberta
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Cancer upgrading during Active surveillance by micro-ultrasound and MRIImmediately after biopsy.
The primary outcome will be detection of ≥Grade Group 2 by each biopsy, technique in combination with the systematic biopsy.